Revenue cycle management has been a target for AI automation for over a decade. The gap between the vendor promises and the actual production deployments remains large. This piece focuses on what works, why it works, and what the clinical and technical prerequisites are.
Pre-Authorisation: The Highest-ROI Starting Point
Pre-authorisation delays are a direct cost - they delay procedures, add administrative burden and when they fail, they result in denials that are expensive to appeal. An AI agent that handles pre-auth submission has a clear, measurable input (the procedure requiring authorisation, the patient's insurance details, the clinical documentation), a clear output (the submitted pre-auth request and the tracked response), and a clear success metric (cycle time and first-pass approval rate).
"Pre-auth automation is attractive precisely because the workflow is well-defined, the failure modes are known and the ROI is directly measurable against baseline cycle times."
The Data Governance Prerequisite
Healthcare AI deployments that fail almost always fail on data governance rather than technology. Patient data isolation, consent-aware access controls, role-based data access and audit trails are not features you add to a working system - they are architecture decisions you make before the first line of code.
FHIR Integration and Why It Matters
HL7 FHIR is the most important standard in healthcare interoperability. An AI agent that integrates through FHIR-compliant APIs accesses patient data through a structured, versioned, governable interface - one that your HIS vendor maintains, documents and supports across upgrades. This is the integration path that survives the long term.